Skip to main content
Erschienen in: Obesity Surgery 10/2020

26.05.2020 | Original Contributions

Elastic Fibers Density: a New Parameter of Improvement of NAFLD in Bariatric Surgery Patients

verfasst von: Carine Leite, Rodrigo Tzovenos Starosta, Eduardo Neubarth Trindade, Eduardo de Melo Monteiro, Pedro Funari Pereira, Manoel Roberto Maciel Trindade, Mário Reis Álvares-da-Silva, Carlos Thadeu Schmidt Cerski

Erschienen in: Obesity Surgery | Ausgabe 10/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Obesity is a major risk factor for nonalcoholic fatty liver disease (NAFLD), affecting 25% of the worldwide population. Weight loss through bariatric surgery can improve much of the liver steatosis, inflammation, and fibrosis. However, it is not known whether there is reversal of the elastic fiber deposition process, triggered by hepatic damage and related to worse prognosis.

Materials and Methods

Individuals submitted to bariatric surgery at our institution, from March 2016 to June 2017, with intraoperative liver biopsy confirming NAFLD were approached. Those who consented were submitted to a second liver biopsy 1 year later and were included. Specimens were sliced and stained with hematoxylin-eosin and Sirius red for histological assessment according to Brunt’s criteria and with orcein for digital analysis morphometrics using ImageJ®. Quantification of elastic fibers was accomplished by corrected integrated density.

Results

Thirty-seven patients were included. Body mass index, metabolic markers, NAFLD activity score, and fibrosis improved 1 year after the procedure. The elastic fiber density showed a significant decrease: 239.3 × 103 absorbance micrometer2 (141.08–645.32) to 74.62 × 103 absorbance micrometer2 (57.42–145.17), p = 0.007.

Conclusion

Liver elastic fiber density decreases with the reversal of NAFLD through weight loss.
Literatur
1.
Zurück zum Zitat Younossi ZM, Henry L, Bush H, et al. Clinical and economic burden of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Clin Liver Dis. 2018;22(1):1–10.PubMedCrossRef Younossi ZM, Henry L, Bush H, et al. Clinical and economic burden of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Clin Liver Dis. 2018;22(1):1–10.PubMedCrossRef
2.
Zurück zum Zitat Younossi ZM, Stepanova M, Negro F, et al. Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine (Baltimore). 2012;91(6):319–27.CrossRef Younossi ZM, Stepanova M, Negro F, et al. Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine (Baltimore). 2012;91(6):319–27.CrossRef
3.
Zurück zum Zitat Pais R, Charlotte F, Fedchuk L, et al. A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver. J Hepatol. 2013;59(3):550–6.PubMedCrossRef Pais R, Charlotte F, Fedchuk L, et al. A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver. J Hepatol. 2013;59(3):550–6.PubMedCrossRef
4.
Zurück zum Zitat Lee Y, Doumouras AG, Yu J, et al. Complete resolution of nonalcoholic fatty liver disease after bariatric surgery: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2019;17(6):1040–60.e11.PubMedCrossRef Lee Y, Doumouras AG, Yu J, et al. Complete resolution of nonalcoholic fatty liver disease after bariatric surgery: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2019;17(6):1040–60.e11.PubMedCrossRef
5.
Zurück zum Zitat Cummings DE, Arterburn DE, Westbrook EO, et al. Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial. Diabetologia. 2016;59(5):945–53.PubMedPubMedCentralCrossRef Cummings DE, Arterburn DE, Westbrook EO, et al. Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial. Diabetologia. 2016;59(5):945–53.PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Nakayama H, Itoh H, Kunita S, et al. Presence of perivenular elastic fibers in nonalcoholic steatohepatitis fibrosis stage III. Histol Histopathol. 2008;23(4):407–9.PubMed Nakayama H, Itoh H, Kunita S, et al. Presence of perivenular elastic fibers in nonalcoholic steatohepatitis fibrosis stage III. Histol Histopathol. 2008;23(4):407–9.PubMed
8.
Zurück zum Zitat Porto LC, Chevallier M, Guerret S, et al. Elastin in alcoholic liver disease. An immunohistochemical and immunoelectron microscopic study. Pathol Res Pract. 1990;186(5):668–79.PubMedCrossRef Porto LC, Chevallier M, Guerret S, et al. Elastin in alcoholic liver disease. An immunohistochemical and immunoelectron microscopic study. Pathol Res Pract. 1990;186(5):668–79.PubMedCrossRef
9.
Zurück zum Zitat Kielty CM, Sherratt MJ, Shuttleworth CA. Elastic fibres. J Cell Sci. 2002;115(Pt 14):2817–28.PubMedCrossRef Kielty CM, Sherratt MJ, Shuttleworth CA. Elastic fibres. J Cell Sci. 2002;115(Pt 14):2817–28.PubMedCrossRef
10.
Zurück zum Zitat Houghton AM, Quintero PA, Perkins DL, et al. Elastin fragments drive disease progression in a murine model of emphysema. J Clin Invest. 2006;116(3):753–9.PubMedPubMedCentralCrossRef Houghton AM, Quintero PA, Perkins DL, et al. Elastin fragments drive disease progression in a murine model of emphysema. J Clin Invest. 2006;116(3):753–9.PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Chen W, Yan X, Xu A, et al. Dynamics of elastin in liver fibrosis: accumulates late during progression and degrades slowly in regression. J Cell Physiol. 2019;234:22613–22.PubMedCrossRef Chen W, Yan X, Xu A, et al. Dynamics of elastin in liver fibrosis: accumulates late during progression and degrades slowly in regression. J Cell Physiol. 2019;234:22613–22.PubMedCrossRef
12.
Zurück zum Zitat Kendall TJ, Dolman GE, Duff CM, et al. Hepatic elastin content is predictive of adverse outcome in advanced fibrotic liver disease. Histopathology. 2018;73(1):90–100.PubMedPubMedCentralCrossRef Kendall TJ, Dolman GE, Duff CM, et al. Hepatic elastin content is predictive of adverse outcome in advanced fibrotic liver disease. Histopathology. 2018;73(1):90–100.PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Hauck M, Seres I, Kiss I, et al. Effects of synthesized elastin peptides on human leukocytes. Biochem Mol Biol Int. 1995;37(1):45–55.PubMed Hauck M, Seres I, Kiss I, et al. Effects of synthesized elastin peptides on human leukocytes. Biochem Mol Biol Int. 1995;37(1):45–55.PubMed
14.
Zurück zum Zitat Kleiner DE, Brunt EM. Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research. Semin Liver Dis. 2012;32(1):3–13.PubMedCrossRef Kleiner DE, Brunt EM. Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research. Semin Liver Dis. 2012;32(1):3–13.PubMedCrossRef
15.
Zurück zum Zitat Trang T, Petersen JR, Snyder N. Non-invasive markers of hepatic fibrosis in patients co-infected with HCV and HIV: comparison of the APRI and FIB-4 index. Clin Chim Acta. 2008;397(1–2):51–4.PubMedCrossRef Trang T, Petersen JR, Snyder N. Non-invasive markers of hepatic fibrosis in patients co-infected with HCV and HIV: comparison of the APRI and FIB-4 index. Clin Chim Acta. 2008;397(1–2):51–4.PubMedCrossRef
16.
Zurück zum Zitat Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313–21.PubMedCrossRef Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313–21.PubMedCrossRef
18.
Zurück zum Zitat Hartig SM. Basic image analysis and manipulation in ImageJ. Curr Protoc Mol Biol. 2013;Chapter 14:Unit14.5. Hartig SM. Basic image analysis and manipulation in ImageJ. Curr Protoc Mol Biol. 2013;Chapter 14:Unit14.5.
19.
Zurück zum Zitat Leite C, Starosta RT, Trindade EN, et al. Corrected integrated density: a novel method for liver elastic fibers quantification in chronic hepatitis C. Surg Exp Pathol. 2020;3(1):4 Leite C, Starosta RT, Trindade EN, et al. Corrected integrated density: a novel method for liver elastic fibers quantification in chronic hepatitis C. Surg Exp Pathol. 2020;3(1):4
20.
Zurück zum Zitat Goodman ZD, Becker RL, Pockros PJ, et al. Progression of fibrosis in advanced chronic hepatitis C: evaluation by morphometric image analysis. Hepatology. 2007;45(4):886–94.PubMedCrossRef Goodman ZD, Becker RL, Pockros PJ, et al. Progression of fibrosis in advanced chronic hepatitis C: evaluation by morphometric image analysis. Hepatology. 2007;45(4):886–94.PubMedCrossRef
21.
Zurück zum Zitat Lomonaco R, Ortiz-Lopez C, Orsak B, et al. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease. Hepatology. 2012;55(5):1389–97.PubMedCrossRef Lomonaco R, Ortiz-Lopez C, Orsak B, et al. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease. Hepatology. 2012;55(5):1389–97.PubMedCrossRef
22.
Zurück zum Zitat Pellicoro A, Aucott RL, Ramachandran P, et al. Elastin accumulation is regulated at the level of degradation by macrophage metalloelastase (MMP-12) during experimental liver fibrosis. Hepatology. 2012;55(6):1965–75.PubMedCrossRef Pellicoro A, Aucott RL, Ramachandran P, et al. Elastin accumulation is regulated at the level of degradation by macrophage metalloelastase (MMP-12) during experimental liver fibrosis. Hepatology. 2012;55(6):1965–75.PubMedCrossRef
23.
Zurück zum Zitat Masugi Y, Abe T, Tsujikawa H, et al. Quantitative assessment of liver fibrosis reveals a nonlinear association with fibrosis stage in nonalcoholic fatty liver disease. Hepatol Commun. 2018;2(1):58–68.PubMedCrossRef Masugi Y, Abe T, Tsujikawa H, et al. Quantitative assessment of liver fibrosis reveals a nonlinear association with fibrosis stage in nonalcoholic fatty liver disease. Hepatol Commun. 2018;2(1):58–68.PubMedCrossRef
24.
Zurück zum Zitat Leng SX, Xue QL, Huang Y, et al. Baseline total and specific differential white blood cell counts and 5-year all-cause mortality in community-dwelling older women. Exp Gerontol. 2005;40(12):982–7.PubMedCrossRef Leng SX, Xue QL, Huang Y, et al. Baseline total and specific differential white blood cell counts and 5-year all-cause mortality in community-dwelling older women. Exp Gerontol. 2005;40(12):982–7.PubMedCrossRef
25.
Zurück zum Zitat Elkind MS, Cheng J, Boden-Albala B, et al. Elevated white blood cell count and carotid plaque thickness: the northern Manhattan stroke study. Stroke. 2001;32(4):842–9.PubMedCrossRef Elkind MS, Cheng J, Boden-Albala B, et al. Elevated white blood cell count and carotid plaque thickness: the northern Manhattan stroke study. Stroke. 2001;32(4):842–9.PubMedCrossRef
26.
Zurück zum Zitat Furuncuoğlu Y, Tulgar S, Dogan AN, et al. How obesity affects the neutrophil/lymphocyte and platelet/lymphocyte ratio, systemic immune-inflammatory index and platelet indices: a retrospective study. Eur Rev Med Pharmacol Sci. 2016;20(7):1300–6.PubMed Furuncuoğlu Y, Tulgar S, Dogan AN, et al. How obesity affects the neutrophil/lymphocyte and platelet/lymphocyte ratio, systemic immune-inflammatory index and platelet indices: a retrospective study. Eur Rev Med Pharmacol Sci. 2016;20(7):1300–6.PubMed
27.
Zurück zum Zitat Veronelli A, Laneri M, Ranieri R, et al. White blood cells in obesity and diabetes: effects of weight loss and normalization of glucose metabolism. Diabetes Care. 2004;27(10):2501–2.PubMedCrossRef Veronelli A, Laneri M, Ranieri R, et al. White blood cells in obesity and diabetes: effects of weight loss and normalization of glucose metabolism. Diabetes Care. 2004;27(10):2501–2.PubMedCrossRef
28.
Zurück zum Zitat Nguyen NT, Varela JE. Bariatric surgery for obesity and metabolic disorders: state of the art. Nat Rev Gastroenterol Hepatol. 2017;14(3):160–9.PubMedCrossRef Nguyen NT, Varela JE. Bariatric surgery for obesity and metabolic disorders: state of the art. Nat Rev Gastroenterol Hepatol. 2017;14(3):160–9.PubMedCrossRef
29.
Zurück zum Zitat Burza MA, Romeo S, Kotronen A, et al. Long-term effect of bariatric surgery on liver enzymes in the Swedish Obese Subjects (SOS) study. PLoS One. 2013;8(3):e60495.PubMedPubMedCentralCrossRef Burza MA, Romeo S, Kotronen A, et al. Long-term effect of bariatric surgery on liver enzymes in the Swedish Obese Subjects (SOS) study. PLoS One. 2013;8(3):e60495.PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat von Schönfels W, Beckmann JH, Ahrens M, et al. Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score). Surg Obes Relat Dis. 2018;14(10):1607–16.CrossRef von Schönfels W, Beckmann JH, Ahrens M, et al. Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score). Surg Obes Relat Dis. 2018;14(10):1607–16.CrossRef
31.
32.
Zurück zum Zitat Meek CL, Lewis HB, Reimann F, et al. The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones. Peptides. 2016;77:28–37.PubMedCrossRef Meek CL, Lewis HB, Reimann F, et al. The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones. Peptides. 2016;77:28–37.PubMedCrossRef
33.
Zurück zum Zitat Fried M. Bariatric and metabolic surgery. Minerva Endocrinol. 2013;38(3):237–44.PubMed Fried M. Bariatric and metabolic surgery. Minerva Endocrinol. 2013;38(3):237–44.PubMed
34.
Zurück zum Zitat Chang SH, Stoll CR, Song J, et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg. 2014;149(3):275–87.PubMedPubMedCentralCrossRef Chang SH, Stoll CR, Song J, et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg. 2014;149(3):275–87.PubMedPubMedCentralCrossRef
Metadaten
Titel
Elastic Fibers Density: a New Parameter of Improvement of NAFLD in Bariatric Surgery Patients
verfasst von
Carine Leite
Rodrigo Tzovenos Starosta
Eduardo Neubarth Trindade
Eduardo de Melo Monteiro
Pedro Funari Pereira
Manoel Roberto Maciel Trindade
Mário Reis Álvares-da-Silva
Carlos Thadeu Schmidt Cerski
Publikationsdatum
26.05.2020
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 10/2020
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-020-04722-x

Weitere Artikel der Ausgabe 10/2020

Obesity Surgery 10/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.